Join the Hypotension group to help and get support from people like you.
Hypotension News
Related terms: Orthostatic Hypotension, Low Blood Pressure
Preoperative Blood Pressure Strategies Yield Similar Postoperative Cognitive Results
FRIDAY, June 6, 2025 – For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies, according to a study...
FDA Warns of Rising Injuries From Misuse of Laughing Gas
MONDAY, March 17, 2025 – Health officials are warning about a rise in injuries linked to the misuse of nitrous oxide, aka laughing gas. The gas, which is used medically as a sedative and in whipped...
Fainting: Simple Tips to Stay Safe
SUNDAY, Feb. 23, 2025 – Fainting can be scary, but it's often harmless. Known medically as syncope, fainting happens when there’s not enough blood flow to the brain, causing a brief loss of c...
Just 5 Extra Minutes of Exercise Per Day Could Lower Blood Pressure
THURSDAY, Nov. 7, 2024 – It doesn't take much: Adding just five minutes of exercise to your daily routine lowers your blood pressure and might cut your odds for heart disease, new research shows....
Machine Learning Can Predict Intradialytic Hypotension During Hemodialysis
WEDNESDAY, Nov. 6, 2024 – Clinical data and machine learning can help to predict intradialytic hypotension (IDH) for patients undergoing hemodialysis, according to a study published online Sept. 14...
FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia
DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) – Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres (ephedrine...
FDA Approves Emerphed (ephedrine sulfate) Ready-to-Use Injection for Hypotension During Anesthesia
Lincolnshire, Ill., April 21, 2020 — Nexus Pharmaceuticals announced today it has received U.S. Food and Drug Administration (FDA) approval for its patent-pending New Drug Application (NDA) Emerphed, ...
FDA Approves Giapreza (angiotensin II) to Treat Dangerously Low Blood Pressure
December 21, 2017 – The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other...
Flamel Technologies Receives FDA Approval of Akovaz (ephedrine sulfate) for Surgical Hypotension
LYON, FRANCE--(Marketwired - May 2, 2016) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's New Drug Application (NDA)...
Flamel Technologies Announces FDA Approval of Vazculep
LYON, FRANCE--(Marketwired - Jun 30, 2014) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA)...
FDA Approves Northera to treat Neurogenic Orthostatic Hypotension
February 18, 2014 – The U.S. Food and Drug Administration today approved Northera capsules (droxidopa) for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often...
Further information
Related condition support groups
Cardiovascular Conditions and Disorders